Mindful Body Awareness Training for Medication for Opioid Use Disorder (MOUD), Pacific Northwest, 2019-2024 (ICPSR 39235)

Version Date: Oct 8, 2024 View help for published

Principal Investigator(s): View help for Principal Investigator(s)
Cynthia Price, University of Washington-Seattle

https://doi.org/10.3886/ICPSR39235.v1

Version V1 ()

  • V2 [2025-06-19]
  • V1 [2024-10-08] unpublished

You are viewing an older version of this study. A newer version is available ()

Slide tabs to view more

The national opioid epidemic requires development of real-world evidence-based treatments for opioid use disorder, including adjuncts to Medication for Opioid Use Disorder (MOUD). Interventions are needed that address the complex needs of patients with opioid use disorder, which include substantial mental health co-morbidity and high rates of chronic pain. This study tested a mind-body intervention, Mindful Awareness in Body-oriented Therapy (MABT), as an adjunct to MOUD across multiple community outpatient clinical settings. MABT, a mindfulness-based intervention, addresses aspects of awareness, interoception, and regulation that may be associated with pain, mental health distress, and behavioral control that increase risk of relapse and poor treatment outcomes.

Price, Cynthia. Mindful Body Awareness Training for Medication for Opioid Use Disorder (MOUD), Pacific Northwest, 2019-2024. Inter-university Consortium for Political and Social Research [distributor], 2024-10-08. https://doi.org/10.3886/ICPSR39235.v1

Export Citation:

  • RIS (generic format for RefWorks, EndNote, etc.)
  • EndNote
United States Department of Health and Human Services. National Institutes of Health (R33AT9932)
Inter-university Consortium for Political and Social Research
Hide

2019 -- 2024
2019 -- 2024
Hide

The specific aims of this study were to evaluate the effectiveness of MABT + MOUD compared to MOUD only to:

  1. reduce opioid use and other illicit substances;
  2. improve mental and physical health; and
  3. improve interoceptive awareness and mindfulness skills.

Randomized, two-group (n = 165/165), repeated measures design comparing those who receive MABT and MOUD to MOUD only. Assessments were administered at baseline, post-intervention (3 months from baseline), and at 6, 9, and 12 months.

Individuals with opioid use disorder receiving medication for treatment were recruited to the study at six community clinics in the Pacific Northwest of the United States. Eligibility criteria included being over 18 years of age, and stable on medication (at least 2 months of treatment).

Cross-sectional

Adult individuals in treatment for opioid use disorder.

Individual, Study group

Variables in this study pertain to pain, drug use, and mental health. Demographic variables include gender and race.

303 individuals enrolled in the clinical trial.

Scales used in this study include the Timeline Followback interview, GAD-7, PHQ-9, PCL-5, BPI, MAIA, DERS-Short Form, and Frieberg Mindfulness Questionnaire (FMQ).

Hide

2024-10-08

Hide